Buz Investors Largest Marijuana Companies 2017 Looking for marijuana companies with high returns has become something of a craze in the market. After all, in 2016 we witnessed some huge growth in weed companies, some in the vicinity of 300% and above. Investors high on the pot market are looking for marijuana companies 2017 to deliver similar results. As such, there’s a good bit of buzz surrounding the top marijuana stocks and just how far they can go.
Some view the high profit marijuana companies as an emerging industry capable of creating overnight millionaires the way tech booms did in the late 2000s. And we all know the heavy cost of missing out. Figuring out how and when to invest in marijuana stocks is crucial to any investor looking to jump on the weed stock surge.
The opportunity to take advantage of a rapidly developing market in its embryonic stage doesn’t come along very often. Here’s a cautionary note: about a decade ago a Harvard student invited five people to his dorm to discuss a business opportunity. Of the five, only two showed up. That decision made them both billionaires (Dustin Moskovitz $9.9 billion and Eduardo Saverin $5.8 billion). You’ve probably seen The Social Network and can guess who the Harvard student was: Mark Zuckerberg.
First, the good news. According to a Gallup, Inc. poll from October 2016, 60% of Americans now approve of legalizing marijuana. That’s the highest percentage recorded in 47 years that public approval of the drug has increased and this bodes well for the industry at large. The U.S., after all, is a giant market and if recreational marijuana legalization ever were to pass on a federal level (which I believe is inevitable, the only variable is the time frame), it would open up vast streams of revenue for the nascent industry. (Source: “Support for Legal Marijuana Use Up to 60% in U.S.,” Gallup, Inc., October 19, 2016.)
White House Press Secretary Spicer is no fan of pot either. “I do believe that you’ll see greater enforcement,” said Spicer during a press briefing in late February. “There’s a big difference between the medical use … [and] recreational use, which is something the Department of Justice will be further looking into.” (Source: “Marijuana sellers face uncertainty under Trump,” The Hill, March 8, 2017.)
U.S. President Donald Trump has been more muted on his stance concerning weed, but don’t expect any big changes in policy coming out of this administration, at least not positive ones for marijuana
Besides having the best ticker in the pot business, Canopy Growth Corp (TSE:WEED) has a great many factors that make it one of the top marijuana stocks in 2017.
The skinny on Insys Therapeutics Inc (NASDAQ:INSY) is that it is one of the fastest growing companies, period.
Through the sale of “Syndros,” the only U.S. Food and Drug Administration (FDA)-approved drug to treat nausea and vomiting caused by chemotherapy, the company has found an untapped niche in the medical marijuana business.
GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH) has been in the medicinal marijuana game for a long time now. Having researched cannabis-based treatments since 1990, there’s a strong pedigree there that should make investors feel comfortable with the company. (Source: “Top 4 Medicinal Marijuana Stocks to Watch for 2017 (ABBV, GWPH),” Investopedia, February 27, 2017.)
Click here for reuse options!